返回 Agenda
[V3-S3] TransCelerate: Innovation through Collaboration
Session Chair(s)
Norie Miki-Yasuda, PHD
Head of Clinical Operations Europe, Canada, Australia & New Zealand, Boehringer Ingelheim Pharma GmbH & Co. KG, Germany
“If you want to go fast, go alone; if you want to go far, go together.” Harnessing the power of collaboration can truly alter the healthcare landscape. This session will present TransCelerate’s perspectives around the next generation of collaborations. How will we need to work together differently as regulators, sponsors, patients, sites, and technologists are brought together? How can collaborations defy the bounds of innovation and accelerate disease prevention, diagnosis, treatment, and?—?ultimately?—?cures? This thought-provoking conversation will bring together a diverse panel of senior executives from TransCelerate Member Companies to discuss the many solutions that have been developed across 19 companies to evolve the clinical trials paradigm. Attendees will learn about how TransCelerate has been solving challenges with Regulators in the Pharmacovigilance space, redefining the Site Investigator experience through novel technologies, and utilizing model frameworks for eConsent and eLabels to progress the industry towards digitally-supported, patient-centric trials.
Speaker(s)
Gareth H Morgan, MBA, MS
Vice President, Management & Clinical Development, Shionogi USA Inc., United States
An Overview of TransCelerate BioPharma, Inc.
Toshiharu Sano, RPH
Associate Vice President, MSD, Japan
TransCelerate Activities in Japan
Ken Kubota, PHD
Vice President for Pharmacovigilance Operations, Astellas Pharma Inc., United States
Key Initiative Update: Pharmacovigilance
Kouichi Mitsuhashi
RBSL, Clinical Operations, MSD K.K., Japan
Key Initiative Update: SIP (Shared Investigator Platform)
Yosuke Chiyomori
Clinical Development Manager, Trial Mgmt,Clinical Development Ops & Innovations, Eli Lilly Japan K.K., Japan
eLabels in Clinical Supplies